Valesca Retèl

22PUBLICATIONS
52CO-AUTHORS
Epidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPacific Peoples youth and familyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Dec 31, 2025
Hospital-based real-world evidence in health technology assessment: insights from a scoping review of European, Australian and North American guidance and expert interviews.

Zainab Al-Khayat, Nora Franzen, Valesca P Retèl

|Dec 19, 2025
Budget Impact Analysis of Hyperthermic Intraperitoneal Chemotherapy With Interval Cytoreductive Surgery in Ovarian Cancer.

Madelief Schreuder Goedheijt, Ruby M van Stein, Simone N Koole

|Jul 09, 2025
Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors.

Zakile A Mfumbilwa, Janneke A Wilschut, Harry J M Groen

|Jun 02, 2025
Socioeconomic impact among and socioeconomic support services for adolescents and young adults with cancer: A European perspective.

Julie M Vancoppenolle, Silvie H M Janssen, Nora Franzen

|Dec 16, 2024
An early economic evaluation of active surveillance for low-risk ductal carcinoma <i>in situ</i>.

Danalyn Byng, Michael Schaapveld, Esther H Lips

|Sep 11, 2024
High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providers.

Joost G E Verbeek, Leyla Azarang, Luis E Pilli

Pageof 4

Frequent Collaborators

5 joint publications

Wim van Harten

4 joint publications

Martijn Simons

4 joint publications

Bram Ramaekers

4 joint publications

Manuela Joore